Ligand id: 3969

Name: bradanicline

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 58.37
Molecular weight 361.18
XLogP 3.75
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Bradanicline has completed Phase II clinical trials as a potential treatment for the cognitive impairment associated with schizophrenia [2] and attention deficit/hyperactivity disorder (ADHD).